NCT07266428
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07266428
Title A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ottimo Pharma Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | IRL | AUS

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
South Texas Accelerated Research Therapeutics (START) Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
South Texas Accelerated Research Therapeutics (START) RECRUITING San Antonio Texas 78229 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
Cancer Research SA RECRUITING Adelaide Australia Details
Chris O'Brien Lifehouse RECRUITING Camperdown 2050 Australia Details
Linear Clinical Research RECRUITING Nedlands 6009 Australia Details
START Dublin Early Phase Clinical Trials Unit RECRUITING Dublin D07 R2WY Ireland Details
Auckland City Hospital RECRUITING Auckland 1023 New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field